Biocompatible in situ hydrogel

Patent metadata

Field	Value
Publication number	US-9844597-B2
Application number	US-201414782999-A
Country	US
Kind code	B2
Filing date	Apr 17, 2014
Priority date	Apr 18, 2013
Publication date	Dec 19, 2017
Grant date	Dec 19, 2017

Abstract

The present invention provides compositions, and related kits and methods, for formation of hydrogels. The compositions comprise one or more chemically crosslinkable agents dissolved in an aqueous solution to form a precursor solution. The chemically crosslinkable agents useful in the present invention are selected from polymers modified with a molecule selected from acrylate, maleimide, vinylsulfone, N-hydroxysuccinimide, aldehyde, ketone, carbodiimide, carbonate, iodoacetyl, mercaptonicotinamide, quinone, thiol, amine, and combinations thereof. The precursor solution is characterized as being in an aqueous form at a non-physiologic physical-chemical condition and undergoing gelation when in contact with another fluid or body at a physiologic physical-chemical condition.

First claim

What is claimed is:

1. A composition comprising:
an aqueous solution of at least two chemically crosslinkable polymers, wherein the aqueous solution including the at least two chemically crosslinkable polymers is at a non-physiological physical-chemical condition comprising at least one of: a temperature below 10° C., and a pH of 6.5 or lower;
wherein the at least two chemically crosslinkable polymers comprise a first polymer and a second polymer,
wherein the first polymer comprises at least one molecule selected from acrylate, maleimide, vinylsulfone, N-hydroxysuccinimide, aldehyde, and iodoacetyl,
wherein the second polymer comprises at least one molecule selected from mercaptonicotinamide, quinone, thiol, and amine,
wherein the aqueous solution is non-buffered saline in which the at least two chemically crosslinkable polymers are dissolved, and
wherein the aqueous solution is not a hydrogel and is in a non-gelling state.

2. The composition of claim 1 , further comprising a viscosity modulating agent.

3. The composition of claim 1 , further comprising at least one of a physically crosslinkable agent and a viscosity modulating agent.

4. The composition of claim 1 , wherein each chemically crosslinkable agent is a polysaccharide.

5. The composition of claim 2 , wherein the viscosity modulating agent is a salt or a polymer that changes the viscosity of the aqueous solution.

6. The composition of claim 2 , wherein the viscosity of the aqueous solution after modulation is 0.5 Centipoise to 100000 Centipoise.

7. The composition of claim 1 , further comprising at least one of a salt, an organic solvent, a drug, and an imaging agent.

8. The composition of claim 1 , further comprising at least one of a drug and an imaging agent that is conjugated on at least one of the chemically crosslinkable agent, a physically crosslinkable agent, and a viscosity modulating agent.

9. The composition of claim 1 , wherein the chemically crosslinkable agent comprises at least one polymer selected from hyaluronic acid, polyethylene glycol, dextran, carboxymethyl cellulose, polyvinyl alcohol, alginate, and cyclodextran.

10. A method of foaming a hydrogel within a space in a body, comprising:
injecting a composition according to claim 1 into the space;
triggering the formation of a hydrogel within the space, the triggering occurring when the aqueous solution contacts at least one of the body and a body fluid within the space; and
allowing the hydrogel to form within the space.

11. The method of claim 10 , wherein the forming of the hydrogel comprises covalently bonding the at least two chemically crosslinkable polymers.

12. The method of claim 10 , wherein the aqueous solution further comprises at least one of a physically crosslinkable agent and a viscosity modulating agent.

13. The method of claim 12 , wherein the forming of the hydrogel comprises physically bonding the physically crosslinkable agent.

14. The method of claim 10 , wherein the triggering of the formation of a hydrogel further comprises a trigger by a change in at least one of temperature, ionic strength, salt composition, organic solvent content, and water content, when the solution is in contact with at least one of the body and the body fluid.

15. The method of claim 14 , wherein the change in temperature trigger comprises a temperature difference between the solution being injected, at a temperature below 10 degrees Celsius, and a body fluid, at a temperature between 25 and 45 degrees Celsius.

16. The method of claim 10 , wherein the forming of the hydrogel takes 1 second to 2 hours.

17. The method of claim 10 , wherein the space in the body is a lumen in the body.

18. The method of claim 10 , wherein the space in the body is a cavity in the body.

19. The method of claim 10 , wherein the composition further comprises a drug.

20. The composition of claim 1 , wherein the first polymer comprises a vinylsulfone, and wherein the second polymer comprises a thiol.

21. The composition of claim 1 , wherein the composition is configured such that, when in contact with a body or body fluid at a physiological physical-chemical condition comprising a buffered system at a pH in a range of from 7.0 to 8.0 and a temperature in a range of from 30° C. to 40° C., the aqueous solution is triggered by exposure to the physiological physical-chemical condition into forming a hydrogel by a chemical crosslinking reaction between the chemically crosslinkable polymers.

22. The composition of claim 1 , wherein the non-buffered saline is normal saline.

23. A composition for drug delivery comprising a composition according to claim 1 that further comprises a drug.

Assignees

• Hong Kong Univ Of Science And Technology
• Univ Hong Kong Sci & Tech

Inventors

• Chau Ying
• Yu Yu
• Zhong Jieying

Classifications

• A61K47/61

  the organic macromolecular compound being a polysaccharide or a derivative thereof · CPC title

• C08B37/0072

  Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates · CPC title

• A61K49/0438

  Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol · CPC title

• A61K49/0442

  Polymeric X-ray contrast-enhancing agent comprising a halogenated group · CPC title

• C08L2205/02

  containing two or more polymers of the same C08L -group · CPC title